Evidence map›Paper›PMID 23920516›Full record

SynthesisStudies in health technology and informatics2013

Automated synthesis and visualization of a chemotherapy treatment regimen network.

Jeremy Warner, Peter Yang, Gil Alterovitz

Abstract readMeta-AnalysisReview
In one paragraph

Synthesis in Studies in health technology and informatics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jeremy WarnerDepartment of Medicine, Division of Hematology & Oncology, Vanderbilt University, Nashville, TN, USA.
Peter Yang
Gil Alterovitz

Funding

Automated Integration of Biomedical KnowledgeR01HG004836 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI ALTEROVITZ, GIL · 2009 to 2010
$856k
A Holistic Approach to Information Processing for Biomedical NetworksR00LM009826 · NLM · BOSTON CHILDREN'S HOSPITAL · PI ALTEROVITZ, GIL · 2010 to 2012
$727k
Beyond Association: Predictive Modeling of Nicotine DependanceR21DA025168 · NIDA · BRIGHAM AND WOMEN'S HOSPITAL · PI ALTEROVITZ, GIL · 2008 to 2009
$350k
NHGRI NIH HHS 1R01HG004836-01NHGRI NIH HHS R01 HG004836NIDA NIH HHS 5R21DA025168-02NIDA NIH HHS R21 DA025168NLM NIH HHS 4R00LM009826-03NLM NIH HHS R00 LM009826
6 · The paper itself

Abstract

Cytotoxic treatments for cancer remain highly toxic, expensive, and variably efficacious. Many chemotherapy regimens are never directly compared in randomized clinical trials (RCTs); as a result, the vast majority of guideline recommendations are ultimately derived from human expert opinion. We introduce an automated network meta-analytic approach to this clinical problem, with nodes representing regimens and edges direct comparison via RCT(s). A chemotherapy regimen network is visualized for the primary treatment of chronic myelogenous leukemia (CML). Node and edge color, size, and opacity are all utilized to provide additional information about the quality and strength of the depicted evidence. Historical versions of the network are also created. With this approach, we were able to compactly compare the results of 17 CML regimens involving RCTs of 9700 patients, representing the accumulation of 45 years of evidence. Our results closely parallel the recommendations issued by a professional guidelines organization, the National Comprehensive Cancer Network (NCCN). This approach offers a novel method for interpreting complex clinical data, with potential implications for future objective guideline development.

Indexed as

AlgorithmsDecision Support Systems, ClinicalUser-Computer InterfaceDiagnosis, Computer-AssistedDrug Therapy, Computer-AssistedHumansLeukemia, MyeloidPattern Recognition, AutomatedSoftware

Identifiers

PMID23920516
PMCPMC4075319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.